DJIA 17,387.21 -291.49 -1.65%
NASDAQ 4,681.50 -90.27 -1.89%
S&P 500 2,029.55 -27.54 -1.34%
market minute promo

325.98 -2.02 (-0.62%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IBB $325.98 -0.62%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $323.62
Previous Close $328.00
Daily Range $323.62 - $329.20
52-Week Range $207.48 - $329.20
Market Cap $7.4B
P/E Ratio -1,426.09
Dividend (Yield) $0.22 (0.2%)
Ex-Dividend Date
Dividend Pay Date
09/24/14
09/30/14
Volume 1,432,792
Average Daily Volume 1,616,613
Current FY EPS $0.00

Sector

Financials

Industry

Financial Services

iShares NASDAQ Biotechnology Index (ETF) (IBB) Description

The investment seeks investment results that correspond generally to the price and yield performance before fees and expenses of the NASDAQ Biotechnology Index (the underlying index). Website: http://www.ishares.com/

News & Commentary Rss Feed

Pharma Stocks Could Be in Deep Trouble in 2015. Here's Why.

Costly new drugs have driven pharma stock prices to all-time highs over the last two years. Here's why this trend might come to a screeching halt.

Will You Miss The Netflix Ride To $1,000?

Tech ETF IBB Brings Plenty Of Risk But It Fits Nicely In A Portfolio

With The Fed Fading Into The Shadows, Investors Look Overseas For New Catalysts

A New Biotech ETF Looks To Bring The Genomic Revolution To Investors

Will Mario Draghi Put A Floor Under Oil?

Gilead: A Bullish Update

A New Biotech ETF Targets Companies In Late Stage Clinical Trials

ALPS Puts Twist On Biotech Investing With Medical Breakthrough ETF

ALPS Puts Twist on Biotech Investing with Medical Breakthrough ETF - ETF News And Commentary

US Equity Markets Sink Post-NFP

Today's financial recap and tomorrow's financial outlook.

See More IBB News...

IBB's Top Competitors

IBB $325.98 (-0.62%)
Current stock: IBB
VTA $11.74 (0.09%)
Current stock: VTA
NCV $8.91 (-0.67%)
Current stock: NCV
ZTR $13.75 (-0.51%)
Current stock: ZTR